Why the study?
Cognitive impairment affects heart failure patients and worsens clinical outcomes, but whether computerized cognitive training can improve cognitive functions in this population was unknown.
Does a three-week computerized cognitive training program improve cognitive function in patients with stable heart failure?
Does a three-week computerized cognitive training program improve cognitive function in patients with stable heart failure?
A three-week computerized cognitive training program yields significant but temporary improvements in cognitive function among patients with stable heart failure.
Cognitive gains from training in stable heart failure may aid adherence; leaves open effects on morbidity or mortality.
Patients with heart failure are usually affected by cognitive impairment, which is associated with lower adherence to treatments and higher morbidity and mortality. Previous studies in healthy samples showed that cognitive functions were improved after cognitive training up to a very old age. We therefore investigated the effect of a three-week computerized cognitive training on cognitive functions in patients with heart failure. 107 patients with stable heart failure (male = 88%, median age = 69 years, range = 31 to 84 years) participated in the study and were followed up at three and six months. Participants were either randomized to a cognitive training group that trained shifting and working memory, an active control group that trained general knowledge or a waiting list control group. Significant performance gains occurred on the trained tasks for shifting and working memory as well as transfer of these gains to overall cognitive performance, particularly working memory, short-term memory, episodic memory and processing speed. Improvements in overall cognitive performance were stable at three-month follow-up, but not after six months. Cognitive training led to broad and sustained cognitive gains in patients with stable heart failure that may support adherence and reduce morbidity and mortality. These effects need to be further investigated in controlled randomized clinical trials. ClinicalTrials.gov registration Identifier. NCT02415517.
No takes yet. Share an insight, caveat, or question.
Wedegärtner et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: